Skip to main content

Motion To Dismiss Opioid Lawsuit Denied

Motion To Dismiss Opioid Lawsuit Denied

Motion To Dismiss Opioid Lawsuit Denied

Introduction

On Tuesday, Suffolk Superior Court Judge Janet Sanders denied a motion filed to dismiss a lawsuit filed against the Sackler family, claiming them responsible for the opioid crisis.

Massachusetts Attorney General Maura Healey had alleged Purdue Pharma, the Sackler family, and other top executives for fuelling the opioid-addiction in the state. A motion to dismiss the lawsuit was filed by the Sacklers and other board of directors members in April, claiming the lawsuit to be divisive, inflammatory and misleading.

The Sacklers argued, stating that the court lacked jurisdiction as the individuals didn't personally participate in the conduct as outlined in the lawsuit. 

Judge Sanders rejected the motion stating that it is the defendants' responsibility to be on notice of deceptive corporate conduct and to report instances of abuse and diversion where applicable. Also, Purdue's attempt to escape the lawsuit was ceased by Judge Sanders last month, where the company had argued the claims were barred by federal preemption because the addictive drugs were approved by the U.S. Food and Drug Administration.

Opioid lawsuits are consolidated under MDL No. 2804 (In Re: National Prescription Opiate Litigation) presided by U.S. District Judge Dan Polster.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

FDA Launches New Panel to Review Talc Safety

Categories: Talcum

A panel of independent scientific experts convened this week at the request of the U.S. Food and Drug Administration (FDA) to evaluate the potential health risks associated with talc…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!